Fonar executives hope to hear soon whether their financial filing earlier this week will bring them into NASDAQ compliance.
Fonar hangs in limbo
Fonar executives hope to hear soon whether their filing earlier this of its Form 10-K for the fiscal year ended June 30, 2009, will bring the company into compliance with NASDAQ’s continued listing requirements. The maverick manufacturer and vendor of MR scanners expects a decision from the stock exchange shortly, according to the company.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.